KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsR&D In ProcessShares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

AbbVie (ABBV) Shares Repurchased (2016 - 2025)

Historic Shares Repurchased for AbbVie (ABBV) over the last 13 years, with Q3 2025 value amounting to $4.0 million.

  • AbbVie's Shares Repurchased fell 7647.06% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 133.04%. This contributed to the annual value of $1.7 billion for FY2024, which is 1338.74% down from last year.
  • Latest data reveals that AbbVie reported Shares Repurchased of $4.0 million as of Q3 2025, which was down 7647.06% from $12.0 million recorded in Q2 2025.
  • In the past 5 years, AbbVie's Shares Repurchased ranged from a high of $2.0 billion in Q1 2023 and a low of $3.0 million during Q4 2023
  • In the last 5 years, AbbVie's Shares Repurchased had a median value of $10.0 million in 2021 and averaged $372.5 million.
  • Its Shares Repurchased has fluctuated over the past 5 years, first tumbled by 9694.66% in 2022, then soared by 1183333.33% in 2024.
  • AbbVie's Shares Repurchased (Quarter) stood at $131.0 million in 2021, then plummeted by 96.95% to $4.0 million in 2022, then dropped by 25.0% to $3.0 million in 2023, then skyrocketed by 11833.33% to $358.0 million in 2024, then tumbled by 98.88% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $12.0 million for Q2 2025, and $961.0 million during Q1 2025.